Please login to the form below

Not currently logged in
Email:
Password:

Turnstone Biologics bolsters leadership team

Kris Elverum and José Otero join the group

Kris ElverumCanadian immuno-oncology company Turnstone Biologics has strengthened its leadership team with the addition of two new hires.

Kris Elverum (pictured right) joins as its chief business officer with more than 12 years’ experience in the pharmaceutical/biotech industry with expertise in corporate strategy, business development, commercial and operations.

Prior to his new role, he was chief business officer at SQZ Biotech, a clinical-stage group focusing on developing cell therapies.

He said: “I’m excited to join Turnstone at this clinical stage in the company’s growth.

“Oncolytic viruses and cancer vaccines have the potential to benefits a wide range of patients living with cancer, and the company’s proprietary viral platform technology is at the forefront of this emerging field.”

José OteroAdditionally, the company has also appointed José Otero (pictured left) as its vice president, manufacturing and CMC following 15 years experience in the biopharmaceutical industry, including bioprocess development, manufacturing, CMC of vaccines and biologics.

Otero joins from Seres Therapeutics, where he was vice president of bioprocess development and manufacturing.

Prior to his role at Seres, Otero served Merck & Co as its director of engineering.

Sammy Farah, chief executive officer, Turnstone Biologics, said: “The addition of industry veterans Kris and José further bolsters our leadership team and comes at a critical time for our company as we advance clinical development of our next-generation oncolytic viral immunotherapies.”

1st September 2017

From: Sales

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Bedrock Group

Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...

Latest intelligence

PME Jan cover
AstraZeneca’s focus on diagnosing and managing chronic kidney disease
People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...
Delphi Technique Virtual Co-creation: A Customer Story
How a client leveraged the Delphi technique to co-create a consensus statement and algorithm using virtual touchpoints....
AI healthcare
Three ways AI will change healthcare in the next decade
Looking forward, there is no doubt that AI will continue to take centre stage in global healthcare initiatives...

Infographics